Rotem in postpartum hemorrhage
- PMID: 25214195
- PMCID: PMC4162101
- DOI: 10.1182/blood-2014-07-590349
Rotem in postpartum hemorrhage
Abstract
In this issue of Blood, Collins et al describe the value of fibrinogen and fibrinogen-based Rotem (Fibtem) as a predictors of severe postpartum hemorrhage among women with persistent postpartum hemorrhage. Fibtem seems to be a promising, fast, point-of-care measure for progression to severe hemorrhage. However, before implementation in clinical practice, there are a number of questions that need to be addressed.
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interests.
Comment on
-
Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study.Blood. 2014 Sep 11;124(11):1727-36. doi: 10.1182/blood-2014-04-567891. Epub 2014 Jul 14. Blood. 2014. PMID: 25024304 Clinical Trial.
References
-
- Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood. 2014;124(11):1727–1736. - PubMed
-
- Abdul-Kadir R, McLintock C, Ducloy A-S, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014;54(7):1756–1768. - PubMed
-
- Chitlur M, Sorensen B, Rivard GE, et al. Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia. 2011;17(3):532–537. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources